Monday, April 11, 2011

Anakinra

Introduction:

Anakinra is an IL-1 receptor antagonist.

Action:
The treatment with this drug causes slowing of process of moderate to serious rheumatoid arthritis.

The drug may be used alone or in combination with other drugs.

Administration:
It is administered subcutaneously.

Adverse effects:
It may cause headache, nausea, vomiting and injection site reactions.
Post a Comment